Saudi Arabia carries one of the highest diabetes burdens globally over 18% adult prevalence Treatment adherence remains a critical challenge, particularly around insulin initiation Reducing the annual injection burden from 365 to 52 is not a minor convenience it is a clinical differentiator For millions living with T2DM, daily injections remain one of the most significant barriers to insulin initiation and long-term adherence
See also: AMA commentary at ama-assn.org CMS
Unlike semaglutide which activates only GLP-1 receptors, or tirzepatide which targets GLP-1 and GIP, retatrutide simultaneously activates three hormone receptors
Regional Insights North America Yerba Mate Market Trends North America is set to command a considerable portion of the yerba mate market share at approximately 30% in 2026, driven by rising health consciousness, growing interest in natural energy alternatives, and successful integration into mainstream retail channels
Semaglutide $159/mo Doctor personalized plans, just for you Lose up to 25% of your weight All inclusive pricing Real experiences from men like you Real Men, Real Results: Lose 20% of Your Weight Medications are only one part of the program
The most powerful opportunity for the natural products industry is not competing with drugs on acute weight loss but owning the long-term space of helping to maintain a healthy weight